Information on internal Pharmac restructures

OIA response

Thank you for your request dated 7 September 2023 under the Official Information Act 1982 (OIA) for information relating to internal restructures. You requested:

Please release all Consultation- and Decision Documents that were generated and circulated between 1st July 2016 and 30th June 2021 as part of any restructure, reorganisation, or (dis)establishment of a team, business unit or directorate within Pharmac NZ. Please include any instances in which a restructure was planned and consulted on, but ultimately not actioned.

  • Consultation Documents are documents that describe the current state of the team, the reason for proposed changes, the proposed new structures (usually as an org chart), and the impact on roles, reporting lines and responsibilities.
  • Decision Documents are documents that list the feedback that was received, the leadership response to that feedback, and the final decision that was made based on it. They describe the final new structure (usually as an org chart) and the process and timeline for that new structure to take effect.

I have interpreted your request to include formal change process documents such as the change proposals set out by the Chief Executive / Chief People Officer / other individual delegated to initiate change process.

Between 1 July 2016 and 30 June 2021, 3 proposals for team restructures were initiated and concluded, the consultation (proposal) and decision documents relating to these restructures are listed in the table below.





June 2018

[Pharmac Change Proposal] Restructure of the Pharmaceutical Funding Team [PDF, 173 KB]


July 2018

[Pharmac Change Decision] Restructure of the Pharmaceutical Funding Team [PDF, 203 KB]


April 2019

[Pharmac Change Proposal] Administration Support Function Restructure [PDF, 275 KB]


May 2019

[Pharmac Change Decision] Administration Support Function Restructure [PDF, 232 KB]


May 2019

[Pharmac Change Proposal] Creation of a Pharmaceutical Assessment Team [PDF, 292 KB]


June 2019

[Pharmac Change Decision] Creation of a Pharmaceutical Assessment Team [PDF, 247 KB]

Where information is withheld it is done so under the following sections of the Act:

  • S9(2)(a), to protect the privacy of individuals;

In making my decision, I have considered the public interest considerations in section 9(1) of the Act. No public interest has been identified that would be sufficient to override the reasons for withholding that information.

We trust that this information answers your queries. Please note, you have the right to make a complaint to the Ombudsman about our response to your OIA, under section 28(3) of the OIA. Details of how to make a complaint(external link) are on the Ombudsman’s website.

To make information more freely available, we publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this